Editorial commentary: Once-daily combination therapy for uncomplicated malaria: Is this the way forward?

Clinical Infectious Diseases

Volumn 41, Issue 4, 2005, Pages 433-434

  Kokwaro, Gilbert ^a  

^a African Centre for Clinical Trials   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; DIHYDROARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; MEFLOQUINE; PIPERAQUINE; SULFADOXINE; UNCLASSIFIED DRUG; DIHYDROQUINGHAOSU; QUINOLINE DERIVATIVE; SESQUITERPENE;

AFRICA; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; FEVER; GENOTYPE; HUMAN; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; OUTCOMES RESEARCH; PARASITE TRANSMISSION; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RURAL POPULATION; SINGLE DRUG DOSE; ANIMAL; DRUG COMBINATION; DRUG EFFECT; NOTE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; QUINOLINES; SESQUITERPENES;

EID: 23244440142     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432016     Document Type: Editorial

References (12)

1. McGavock H. A review of the literature on drug adherence. In: Partnership in medicine taking: a consultative document. Taking medicines to the best effect. London, United Kingdom: The Royal Pharmaceutical Society of Great Britain, 1996:7.
2. Yeung S, White N. How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health 2005; 10:121-38.
3. White NJ, Nosten F, Looareesuwan S, et al. Averting a malaria disaster. Lancet 1999; 353: 1965-7.
4. White NJ. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 1999; 41:301-8.
5. Amin AA, Hughes DA, Marsh V, et al. The difference between effectiveness and efficacy of antimalarial drugs in Kenya. Trop Med Int Health 2004; 9:967-74.
6. Depoortere E, Guthmann JP, Sipilanyambe N, et al. Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in Maheba refugee settlement, Zambia. Trop Med Int Health 2004; 9:62-7.
7. Depoortere E, Guthman JP, Presse J, et al. Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia. Trop Med Int Health 2005; 10:139-45.
8. Fogg C, Bajunirwe F, Piola P, et al. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated falciparum malaria in Uganda. Am J Trop Med Hyg 2004; 71:525-30.
9. Ashley EA, McGready R, Hutagalung R, et al. A randomized controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin Infect Dis 2005; 41:425-32 (in this issue).
10. Price RN, Nosten F, Luxemburger C, et al. Effect of artemisinin derivatives on malaria transmission. Lancet 1996; 347:1654-8.
11. Mbogo CN, Snow RW, Kabiru EW, et al. Low-level Plasmodium falciparum transmission and the incidence of severe malaria infections on the Kenyan coast. Am J Trop Med Hyg 1993; 49:245-53.
12. Snow RW, Bastos de Azevedo I, Lowe BS, et al. Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa. Acta Trop 1994; 57:289-300.